Medicare Enrolled

Dr. Mohammed Shrit, MD

Hematology (Pathology) Physician · Dayton, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1 WYOMING ST, Dayton, OH 45409
9372082978
In practice since 2005 (20 years)
NPI: 1306831292 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shrit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shrit? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shrit

Dr. Mohammed Shrit is a hematology physician in Dayton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shrit performed 2,889 Medicare services across 1,511 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shrit received a total of $32,959 from 11 pharmaceutical and/or device companies across 77 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology (pathology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shrit is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 38% volume in OH $32,959 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,889
Medicare services
Top 38% in OH for hematology (pathology) physician
1,511
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~144 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
873 $21 $148
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
425 $26 $148
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
377 $31 $150
Additional manual multiplex genetic stain
A microscopic genetic analysis performed manually using an additional multiplex stain procedure on tissue.
261 $49 $150
Genetic test interpretation and report
A healthcare provider reviews the results of genetic testing and provides a written report explaining the findings.
187 $25 $64
Flow cytometry, 16 or more markers
A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties.
163 $65 $279
DNA testing for genetic defects
A laboratory test that analyzes DNA to identify specific genetic abnormalities or mutations. This procedure is used to detect inherited conditions or predispositions associated with genetic defects.
143 $21 $60
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
88 $28 $175
Special tissue stain and interpretation
A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings.
79 $9 $50
Chromosome analysis for genetic defects, 100-300 cells
A laboratory test that examines 100 to 300 cells to analyze chromosomes for genetic defects.
60 $50 $110
Tissue preparation to remove calcium
A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination.
44 $9 $50
Additional genetic sequencing localization
This procedure involves additional genetic sequencing localization work beyond the initial test. It is performed to further analyze genetic material.
44 $25 $161
Blood smear interpretation with written report
A physician examines a blood sample slide under a microscope to analyze blood cells. The doctor provides a written report of their findings.
43 $18 $50
Genetic sequencing localization, initial procedure
This procedure involves the initial process of localizing genetic sequencing. It identifies the specific location of genetic material for further analysis.
42 $32 $161
Bone marrow smear interpretation
A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities.
26 $37 $262
Screening examination of specimen cells
A laboratory test to examine cells from a specimen for signs of disease. The process includes both the screening of the sample and the professional interpretation of the results.
21 $19 $77
Flow cytometry DNA or cell analysis, 9-15 markers
A laboratory test that uses a laser to analyze cells or DNA using 9 to 15 different markers. This technique helps identify and characterize specific cell types or genetic material.
13 $48 $212
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,959
Total received (2018-2024)
Avg $4,708/year across 7 years
Top 7% in OH for hematology (pathology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
11
Companies
77
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,015 (51.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,944 (48.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,069
2023
$5,257
2022
$124
2021
$216
2020
$115
2019
$378
2018
$25,799

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Beckman Coulter, Inc.
$798
Agilent Technologies, Inc.
$174
Tempus AI, Inc
$50
Celgene Corporation
$47
Top 3 companies account for 95.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$17,136
Agilent Technologies, Inc.
$14,114
Beckman Coulter, Inc.
$798
Roche Diagnostics Corporation
$202
Genentech USA, Inc.
$139
AstraZeneca Pharmaceuticals LP
$125
Haemonetics Corporation
$124
Celgene Corporation
$97
Stemline Therapeutics Inc.
$95
Merck Sharp & Dohme Corporation
$80
Tempus AI, Inc
$50
Top 3 companies account for 97.2% of all-time payments
Associated products mentioned in payments ›
DXH 900 Hematology System · ELZONRIS · KEYTRUDA · NGS · OMNIS · Omnis · PD-L1 · REBLOZYL · SOLIRIS · Sureslect · TAGRISSO · TD VENTANA Research and Development · TEG6S HEMOSTASIS SYSTEM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology (pathology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for hematology (pathology) physician in OH.

Looking for a hematology physician in Dayton?
Compare hematology physicians in the Dayton area by procedure volume, costs, and industry payment transparency.
Browse hematology physicians nearby

Geographic Context

Hematology physicians within 10 mi
1
Per 100K population
0.2
County median income
$64,403
Nearest hospital
MIAMI VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shrit is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shrit experienced with tissue staining for diagnosis, additional?
Based on Medicare claims data, Dr. Shrit performed 873 tissue staining for diagnosis, additional services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shrit receive payments from pharmaceutical companies?
Yes. Dr. Shrit received a total of $32,959 from 11 companies across 77 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shrit's costs compare to other hematology physicians in Dayton?
Dr. Shrit's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shrit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →